Human recombinant BCMA:Fc

ENZOALX522026C050

ENZOALX522026C050

Pk:
50 µG
Protein/peptide type:
Recombinant
Species:
Human
Seq:
02
Biological activity:
Blocks the binding of BAFF and APRIL to their receptors BCMA and TACI, inhibiting BAFF- and APRIL-mediated B cell activation.
Reconstitution instructions:
Reconstitute with 50 µl of sterile water. Further dilutions should be made with medium containing 5% fetal calf serum or a carrier protein.
Protein/peptide name:
BCMA:Fc
Purity:
>95% (SDS-PAGE)
Concentration:
1 mg/ml after reconstitution
Formulation:
Lyophilised. Contains PBS.

Produced in HEK 293 cells. The extracellular domain of human BCMA (aa 2-54) is fused at the C-terminus to the Fc portion of human IgG1.